TIGR vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

TIGR

61.5
AI Score
VS
TIGR Wins

HIVE

57.7
AI Score

Investment Advisor Scores

TIGR

62score
Recommendation
BUY

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric TIGR HIVE Winner
Forward P/E 14.9925 62.8931 TIGR
PEG Ratio 0 0 Tie
Revenue Growth 32.4% 73.5% HIVE
Earnings Growth -33.3% -99.9% TIGR
Tradestie Score 61.5/100 57.7/100 TIGR
Profit Margin 18.4% -98.5% TIGR
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD TIGR

Relative Price Performance (Last 90 Days)

TIGR 1M: -13.8% · 3M: -14.2% HIVE 1M: -42.1% · 3M: -34.1%

Current Technical Phase

TIGR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 37

RSI (14): 36.6 · Price: $4.06

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $1.95

Fundamentals Snapshot

Metric TIGR HIVE
Market Cap — —
Forward P/E 4.5 -3.8
Trailing P/E 7.7 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.7%
Gross Margin 0.9% 0.4%
Operating Margin 0.4% -0.6%
EPS 0.54 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TIGR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.